Cat.#: ASSD-111
Description | Propidium iodide (PI) is a widely used red-fluorescent intercalating agent that binds and labels nucleic acids. When bound to the nucleic acids, its fluorescence is enhanced 20- to 30-fold. Frequently used with Oxazole Yellow (YP1) when staining for apoptotic and necrotic cells as apoptotic cells remain impermeant to propidium iodide but permeable to Oxazole Yellow (YP1). |
Synonyms | PI |
Size | 10 mg, 50 mg |
Applications | Flow cytometry, fluorescent microscopy and confocal laser scanning microscopy. Propidium iodide is membrane impermeant and is therefore frequently used to selectively identify dead cells and is commonly used in flow cytometry to evaluate cell viability. |
Chemical Name | 2,7-Diamino-9-phenyl-10 (diethylaminopropyl)-phenanthridium iodide methiodide |
Molecule Weight | 668.39 |
Molecular formula | C27H34I2N4 |
CAS Number | 25535-16-4 |
PubChem identifier | 104981 |
MDL Number | MFCD00011921 |
Purity | >97% |
Solubility | Soluble in water (5 mM) |
Form | Purple solid |
Excitation | 535 nm |
Emission | 617 nm |
Storage | Store at 4° C |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-157 | Eosin B (AC157) | 1g, 5g | inquiry |
ASSD-153 | Brilliant Blue G (AC153) | 1g | inquiry |
ASSD-220 | Nitrofluorescein, Isomer 2 (AC220) | 1 g | inquiry |
ASSD-180 | Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 (AC180) | 1 mg | inquiry |
ASSD-213 | Fluorescein 6-Maleimide (AC213) | 25 mg, 250 mg | inquiry |
ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg | inquiry |
ASSD-201 | Fluoresceinamine Hydrochloride Isomer 1 (AC201) | 2 g | inquiry |
ASSD-132 | Congo Red (AC132) | 100 mg, 1g | inquiry |
ASSD-173 | FITC-Dextran 70 (AC173) | 100 mg, 500 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.